We are live on ! Find out more
EXEL icon

Exelixis

303 hedge funds and large institutions have $5.24B invested in Exelixis in 2018 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 111 increasing their positions, 86 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $104M | Put options by funds: $33M

133% more funds holding in top 10

Funds holding in top 10: 37 (+4)

29% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 86

21% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 48

3.25% more ownership

Funds ownership: 78.86%82.11% (+3.2%)

3% more funds holding

Funds holding: 294303 (+9)

1% more capital invested

Capital invested by funds: $5.18B → $5.24B (+$69.1M)

Holders
303
Holders Change
+9
Holders Change %
+3.06%
% of All Funds
6.94%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.16%
New
58
Increased
111
Reduced
86
Closed
48
Calls
$104M
Puts
$33M
Net Calls
+$70.9M
Net Calls Change
+$23.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Canada Life
176
Canada Life
Manitoba, Canada
$687K -$57.5K -2,781 -8%
Grantham, Mayo, Van Otterloo & Co (GMO)
177
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$667K +$97.2K +4,700 +18%
OI
178
Oakbrook Investments
Illinois
$655K +$630K +30,450 New
OC
179
Oppenheimer & Co
New York
$627K +$227K +10,997 +61%
Mackenzie Financial
180
Mackenzie Financial
Ontario, Canada
$611K +$121K +5,867 +26%
Man Group
181
Man Group
United Kingdom
$608K -$495K -23,918 -46%
Wolverine Trading
182
Wolverine Trading
Illinois
$606K
VIA
183
Vident Investment Advisory
Georgia
$548K +$125K +6,030 +31%
SAM
184
Securian Asset Management
Minnesota
$540K +$519K +25,090 New
GCP
185
GSA Capital Partners
United Kingdom
$535K -$2.55M -123,500 -83%
WG
186
Winton Group
United Kingdom
$529K -$443K -21,438 -47%
MLICM
187
Metropolitan Life Insurance Company (MetLife)
New York
$497K +$26.1K +1,262 +6%
AIMCA
188
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$497K +$478K +23,100 New
KBC Group
189
KBC Group
Belgium
$478K -$6.38M -308,666 -93%
Zurich Cantonal Bank
190
Zurich Cantonal Bank
Switzerland
$451K
RJFSA
191
Raymond James Financial Services Advisors
Florida
$443K +$61K +2,948 +17%
Cambridge Investment Research Advisors
192
Cambridge Investment Research Advisors
Iowa
$432K +$39.4K +1,903 +10%
BAS
193
Brown Advisory Securities
Maryland
$430K
AB
194
AT Bancorp
Iowa
$430K +$413K +19,949 New
MAM
195
Meeder Asset Management
Ohio
$417K +$196K +9,500 +96%
AA
196
ALPS Advisors
Colorado
$398K -$314K -15,173 -45%
IA
197
IFG Advisory
Georgia
$385K +$167K +8,080 +82%
CSS
198
Cubist Systematic Strategies
Connecticut
$382K -$188K -9,104 -34%
PPCM
199
Pillar Pacific Capital Management
California
$375K +$17.6K +850 +5%
Janney Montgomery Scott
200
Janney Montgomery Scott
Pennsylvania
$371K +$84.7K +4,095 +31%

EXEL Hedge Fund Activity: Q2 2018 in Review

303 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2018, worth a combined $5.24B — up 1.3% from $5.18B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new EXEL positions and 48 closed out — a net gain of 10 holders — while 111 added to existing stakes and 86 trimmed.

The largest buyer was BlackRock, adding an estimated $262M. The largest seller was T. Rowe Price Associates, cutting an estimated $109M.

  • 303 institutional investors held Exelixis (EXEL) as of Q2 2018, up from 294 in Q1 2018.
  • Funds reported $5.24B of Exelixis stock for Q2 2018, up 1.3% quarter-over-quarter.
  • 58 funds opened new Exelixis positions in Q2 2018 and 48 closed out, a net change of +10 holders.
  • The largest Exelixis buyer in Q2 2018 was BlackRock, an estimated $262M added.
  • The largest Exelixis seller in Q2 2018 was T. Rowe Price Associates, an estimated $109M sold.

Based on aggregated 13F filings for Q2 2018.